Last updated: 2026-09-28 10:38:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Bluejay Diagnostics, Inc. (BJDX) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $0,98, with a market capitalization of $953,28K and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,80 to $16,68. This page covers its latest market performance, valuation, price trends and company information.
$953,28K | |
$0,96 | |
$200.000,00 | |
$0,80 | |
$0,92 | |
10,37K | |
5,71M | |
-- | |
$16,68 | |
$0,80 | |
-- | |
-- |
Bluejay Diagnostics, Inc. (BJDX) is trading at $0,98 in pre-market trading as of 2026-09-28 10:10:00, up 5,94% ($0,05) from the previous close of $0,92
Pre-market trading shows how investors are pricing BJDX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Bluejay Diagnostics, Inc. (BJDX) moved from $0,85 to $0,98, representing a gain of 15,50% ($0,13).
The stock traded between $0,81 and $1,03 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 998,76 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 1,1%
BJDX is currently trading at $0,98, placing it 1,1% of the way from its 52-week low of $0,80 to its 52-week high of $16,68. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 6 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Bluejay Diagnostics, Inc. (BJDX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.